Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

D. Issels, Rolf; H. Lindner, Lars; Verweij, Jaap; Wessalowski, Rüdiger; Reichardt, Peter; Wust, Peter; Ghadjar, Pirus; Hohenberger, Peter; K. Angele, Martin; Salat, Christoph; Vujašković, Željko; Daugaard, Soeren; Mella, Olav; Mansmann, Ulrich; Roland Dürr, Hans; Knösel, Thomas; Abdel-Rahman, Sultan; Schmidt, M.; Hiddemann, Wolfgang; Jauch, Karl‐Walter; Belka, Claus; Gronchi, Alessandro

doi:10.1001/jamaoncol.2017.4996

Public

Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

Published in JAMA Oncology • Feb 15, 2018

Authors:

Rolf D. Issels

Lars H. Lindner

Jaap Verweij

Abstract

IMPORTANCE: Patients with soft tissue sarcoma are at risk for local recurrence and distant metastases despite optimal local treatment. Preoperative anthracycline plus ifosfamide chemotherapy improves outcome in common histological subtypes. OBJECTIVE: To analyze whether the previously reported impro...

Subject

Medicine

Ifosfamide

Soft tissue sarcoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!